Polymorphism of gonadotropin action: Clinical implications

Asian Journal of Andrology

Volumn 2, Issue 4, 2000, Pages 241-246

  Huhtaniemi, Ilpo T ^a,b  

^a UNIVERSITY OF TURKU   (Finland)

^b UNIVERSITY OF ABERDEEN   (United Kingdom)

Author keywords

Bioassay; FSH; Glycosylation; Immunometric assay; LH; Mutation; Polymorphism

Indexed keywords

LUTEINIZING HORMONE;

ADOLESCENT; ADULT; AGE; AMINO ACID SEQUENCE; BLOOD; CHILD; FEMALE; GENETIC POLYMORPHISM; GENETICS; HUMAN; MALE; MOLECULAR GENETICS; PHYSIOLOGY; POINT MUTATION; PUBERTY; REVIEW; SEX DIFFERENCE;

ADOLESCENT; ADULT; AGE FACTORS; AMINO ACID SEQUENCE; CHILD; FEMALE; HUMANS; LUTEINIZING HORMONE; MALE; MOLECULAR SEQUENCE DATA; POINT MUTATION; POLYMORPHISM, GENETIC; PUBERTY; SEX FACTORS;

EID: 0034564453     PISSN: 1008682X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (16)

1. Gharib SD, Wierman ME, Shupnik MA, Chin WW. Molecular biology of the pituitary gonadotropins. Endocr Rev 1990; 11: 177-99.
2. Sairam MR, Fleshner P. Inhibition of hormone-induced cyclic AMP production and steroidogenesis in interstitial cells by deglycosylated lutropin. Mol Cell Endocrinol. 1981; 22: 41 -51.
3. Themmen APN, Huhtaniemi IT. Mutations of gonadotropins and gonadotropin receptors; Elucidating the physiology and pathophysiology of pituitart-gonadal function. Endocr Rev 2000; 21: 551-83.
4. Dufau ML, Veldhuis JD. Pathophysiological relationships between the biological and immunological activities of luteinizing hormone. Baillière's Clin Endocrinol Metab. 1987; 1: 153-76.
5. Beitins E, Padmanabhan V. Bioactivity of gonadotropins. Endocr Metab Clin North Amer 1991; 20: 85 -120.
6. Tsatsoulis A, Shalet SM, Robertson WR. Bioactive gonadotrophin secretion in man. Clin Endocr (Oxf) 1991; 35: 193-206.
7. Ulloa-Aguirre A, Midgley ARJr, Beitins E, Padmanabhan V. Follicle-stimulating isohormones: characterization and physiological relevance. Endorc Rev 1995; 16: 765-87.
8. Christin-Maitre S, Vasseur C, Fauser B, Bouchard P. Bioassays of gonadotropins. Methods 2000; 21: 51-7.
9. Veldhuis JD, Johnson ML, Dufau ML. Preferential release of bioactive luteinizing hormone in response to endogenous and low dose exogenous gonadotropin-releasing hormone pulses in man. J Clin Endocrinol Metab 1987; 64: 1275-82.
10. Lucky AW, Rich BH, Rosenfield RL, Fang VS, Roche-Bender N. LH bioactivity increases more than immunoreactivity during puberty. J Pediatr 1980; 97: 205-13.
11. Reiter EO, Beitins E, Ostrea T, Gutai JP. Bioassayable luteinizing hormone during childhood and adolescence and in patients with delayed pubertal development. J Clin Endocrinol Metab 1982; 54: 155-61.
12. Rich BH, Rosenfield RL, Moll GW, Lucky AW, Roche-Bender N, Fang V. Bioactive luteinizing hormone pituitary reserves during normal and abnormal male puberty. J Clin Endocrinol Metab 1982; 55: 140-6.
13. Haavisto A-M, Simberg N, Huhtaniemi I. The bio/immuno ratio of serum LH increases after orchidectomy in prostatic cancer patients and is associated with decreased molecular weight and appearance of isohormones with alkaline pi values. Biol Reprod 1990; 42: 597-602.
14. Beitins E, Axelrod L, Ostrea T, Little R, Badger TM. Hypogonadism in a male with an immunologically active, biologically inactive luteinizing hormone; characterization of the abnormal hormone. J Clin Endocrinol Metab 1981; 52: 1143-9.
15. St Arnaud R, Lachance R, Dupont A, Labrie F. Serum luteinizing hormone (LH) biological activity in castrated patients with cancer of the prostate receiving a pure antiandrogen and in estrogen-pretreated patients treated with an LH-releasing hormone agonist and antiandrogen. J Clin Endocrinol Metab 1986; 63: 297-302.
16. Veldhuis JD, Dufau ML. Estradiol modulates the pulsatile secretion of biologically active luteinizing hormone in man. J Clin Invest 1987; 80: 631-8.